meQuilibrium is a SaaS platform that helps users build resilience, beat stress, and adopt healthy behavior for life. The clinically validated, HIPAA compliant platform, delivers an individualized digital coaching experience via the web and mobile devices. meQuilibrium services two key markets: large enterprise companies, eager to stem the estimated $300 billion they lose each year in employee absenteeism and lost productivity due to stress, and payors and health plans seeking to drive differentiation and innovation in an era of consumer-driven healthcare. meQuilibrium also serves individuals looking to improve the quality of their lives.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
04/16/15 | $9,000,000 | Series B |
Chrysalis Ventures | undisclosed |
08/14/18 | $7,000,000 | Series C |
Chrysalis Ventures HLM Venture Partners Safeguard Scientifics | undisclosed |